Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.09 is 83% below its 5-year average of 0.54, near the low end of its 5-year range (0.00–1.59).
As of the fiscal period ended Wednesday, December 31, 2025. 68.28% below its 12-month average of 0.29.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2025-12-31): 0.09.
QUICK RATIO (ACID-TEST)
0.09
QUICK RATIO (ACID-TEST) AVG TTM
0.29
QUICK RATIO (ACID-TEST) AVG 3Y
0.30
QUICK RATIO (ACID-TEST) AVG 5Y
0.54
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-68.28%
CURRENT VS 3Y AVG
-69.41%
CURRENT VS 5Y AVG
-83.14%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 506 covered companies
CURRENT VS SECTOR MEDIAN
-96.96%
vs the sector median at left
Gelteq Limited Ordinary Shares
Market Cap
$4.81M
Quick Ratio (Acid-Test)
0.09
TTM Avg
0.29
3Y Avg
0.30
5Y Avg
0.54
Market Cap
$5.26M
Quick Ratio (Acid-Test)
1.84
TTM Avg
1.72
3Y Avg
1.97
5Y Avg
1.97
Market Cap
$4.85M
Quick Ratio (Acid-Test)
5.58
TTM Avg
4.46
3Y Avg
3.04
5Y Avg
7.15
Market Cap
$4.80M
Quick Ratio (Acid-Test)
7.22
TTM Avg
2.13
3Y Avg
2.10
5Y Avg
5.04
Market Cap
$5.36M
Quick Ratio (Acid-Test)
3.01
TTM Avg
3.95
3Y Avg
2.52
5Y Avg
4.28
Market Cap
$4.58M
Quick Ratio (Acid-Test)
10.60
TTM Avg
4.75
3Y Avg
13.37
5Y Avg
23.75
Market Cap
$4.50M
Quick Ratio (Acid-Test)
2.73
TTM Avg
3.29
3Y Avg
4.75
5Y Avg
4.47
Market Cap
$5.54M
Quick Ratio (Acid-Test)
1.35
TTM Avg
1.00
3Y Avg
0.98
5Y Avg
1.86
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Gelteq Limited Ordinary Shares (GELS) | $4.81M | 0.09 | 0.29 | 0.30 | 0.54 |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.26M | 1.84 | 1.72 | 1.97 | 1.97 |
| CalciMedica, Inc. (CALC)vs › | $4.85M | 5.58 | 4.46 | 3.04 | 7.15 |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.80M | 7.22 | 2.13 | 2.10 | 5.04 |
| Imunon, Inc. (IMNN)vs › | $5.21M | 1.82 | 1.99 | 2.53 | 3.43 |
| Alzamend Neuro Inc (ALZN)vs › | $5.36M | 3.01 | 3.95 | 2.52 | 4.28 |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.58M | 10.60 | 4.75 | 13.37 | 23.75 |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.50M | 2.73 | 3.29 | 4.75 | 4.47 |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.54M | 1.35 | 1.00 | 0.98 | 1.86 |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.40M | 1.35 | 3.30 | 6.18 | 6.77 |
Quick Ratio
0.09
Excludes inventory
Current Ratio
0.09
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2025-12-31 | 0.09 |
| 2025-09-30 | 0.00 |
| 2025-06-30 | 0.27 |
| 2024-12-31 | 0.79 |
| 2024-06-30 | 0.08 |
| 2024-03-31 | 0.12 |
| 2023-06-30 | 0.66 |
| 2023-03-31 | 0.37 |
| 2022-06-30 | 0.58 |
| 2022-03-31 | 1.38 |
| 2021-06-30 | 1.59 |
